SINEQUAN Drug Patent Profile
✉ Email this page to a colleague
When do Sinequan patents expire, and when can generic versions of Sinequan launch?
Sinequan is a drug marketed by Pfizer and is included in two NDAs.
The generic ingredient in SINEQUAN is doxepin hydrochloride. There are seven drug master file entries for this compound. Forty-nine suppliers are listed for this compound. Additional details are available on the doxepin hydrochloride profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Sinequan
A generic version of SINEQUAN was approved as doxepin hydrochloride by MYLAN PHARMS INC on May 13th, 1986.
Summary for SINEQUAN
US Patents: | 0 |
Applicants: | 1 |
NDAs: | 2 |
Raw Ingredient (Bulk) Api Vendors: | 29 |
Clinical Trials: | 2 |
Patent Applications: | 3,963 |
Formulation / Manufacturing: | see details |
DailyMed Link: | SINEQUAN at DailyMed |
Recent Clinical Trials for SINEQUAN
Identify potential brand extensions & 505(b)(2) entrants
Sponsor | Phase |
---|---|
University of Balamand | Phase 4 |
Mayo Clinic | Phase 2 |
National Cancer Institute (NCI) | Phase 2 |
Anatomical Therapeutic Chemical (ATC) Classes for SINEQUAN
US Patents and Regulatory Information for SINEQUAN
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Pfizer | SINEQUAN | doxepin hydrochloride | CAPSULE;ORAL | 016798-003 | Approved Prior to Jan 1, 1982 | DISCN | Yes | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
Pfizer | SINEQUAN | doxepin hydrochloride | CONCENTRATE;ORAL | 017516-001 | Approved Prior to Jan 1, 1982 | DISCN | Yes | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
Pfizer | SINEQUAN | doxepin hydrochloride | CAPSULE;ORAL | 016798-006 | Approved Prior to Jan 1, 1982 | DISCN | Yes | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
Pfizer | SINEQUAN | doxepin hydrochloride | CAPSULE;ORAL | 016798-001 | Approved Prior to Jan 1, 1982 | DISCN | Yes | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
Pfizer | SINEQUAN | doxepin hydrochloride | CAPSULE;ORAL | 016798-002 | Approved Prior to Jan 1, 1982 | DISCN | Yes | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Expired US Patents for SINEQUAN
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Patent No. | Patent Expiration |
---|---|---|---|---|---|---|---|
Pfizer | SINEQUAN | doxepin hydrochloride | CAPSULE;ORAL | 016798-005 | Approved Prior to Jan 1, 1982 | ⤷ Try a Trial | ⤷ Try a Trial |
Pfizer | SINEQUAN | doxepin hydrochloride | CAPSULE;ORAL | 016798-002 | Approved Prior to Jan 1, 1982 | ⤷ Try a Trial | ⤷ Try a Trial |
Pfizer | SINEQUAN | doxepin hydrochloride | CAPSULE;ORAL | 016798-003 | Approved Prior to Jan 1, 1982 | ⤷ Try a Trial | ⤷ Try a Trial |
Pfizer | SINEQUAN | doxepin hydrochloride | CAPSULE;ORAL | 016798-006 | Approved Prior to Jan 1, 1982 | ⤷ Try a Trial | ⤷ Try a Trial |
Pfizer | SINEQUAN | doxepin hydrochloride | CAPSULE;ORAL | 016798-007 | Approved Prior to Jan 1, 1982 | ⤷ Try a Trial | ⤷ Try a Trial |
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >Patent No. | >Patent Expiration |